Riskpilot← Back to searchSign inGet full accessNORVUE AS
ASActiveOrg 925416509Sinsenveien 49D, 0585 OsloOther education n.e.c. · NACE 8559Est. 20200 employees
Revenue 2024
NOK 323K
+36% vs 2023
EBITDA margin
-61.2%
+9% vs 2023
Equity ratio
-180.3%
Financial strength
Net profit 2024
NOK -171K
+9% vs 2023
| Revenue | NOK 323K | +36% |
| EBITDA | NOK -198K | +9% |
| Net profit | NOK -171K | +9% |
| Total assets | NOK 319K | +24% |
| Equity | NOK -575K | -31% |
| Employees | 0 | — |
Legal name
NORVUE AS
Org number
925416509
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
30. juli 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Tilby undervisning, kurs og rådgivning innen medisisnk ultralyd og relaterte helsetjenester. Selskapet kan også investere i, eie og utvikle virksomheter, eiendeler og verdipapirer, herunder aksjer og andeler i andre selskaper, samt annen virksomhet som naturlig hører sammen med dette. I tillegg kan selskapet tilby medisinke tjenester gjennon sin eiere og konsulenter, herunder legevirksomhet og andre helsefaglige tjenester.
Address
Sinsenveien 49D, 0585 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 12 | 107 | 237 | 323 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −19 | −230 | −57 | −218 | −198 |
| Depreciation & amort. | −4 | −22 | −23 | −21 | −21 |
| EBIT | −23 | −253 | −80 | −239 | −219 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −23 | −253 | −80 | −239 | −219 |
| Tax | −5 | −56 | −18 | −53 | −48 |
| Net profit | −18 | −197 | −62 | −187 | −171 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 104 | 187 | 277 | 258 | 319 |
| Equity | 6 | −190 | −253 | −439 | −575 |
| Long-term debt | 0 | 0 | 0 | 0 | 871 |
| Short-term debt | 98 | 377 | 530 | 697 | 24 |
| Total debt | 98 | 377 | 530 | 697 | 895 |
EBITDA margin
-61.2%
This company
15.8%
Market median
-487% vs market
20202024
Equity ratio
-180.3%
This company
38.2%
Market median
-572% vs market
20202024
Return on equity
-17053400.0%
This company
18.4%
Market median
-92681622% vs market
20202024
Net profit margin
-52.9%
This company
8.1%
Market median
-753% vs market
20202024
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
20202024
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Chairman | 2025 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORVUE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eirik Brekka Tjønnfjord | Deputy Chairman | 0 companies |
| Ai Van Thuy Ho | Board of Directors | 0 companies |
| Ai Phi Thuy Ho | Chairman | 0 companies |
| Tomas Skei | Board of Directors | 0 companies |